Kerndl, Martina https://orcid.org/0000-0001-5060-8944
Musiejovsky, Laszlo https://orcid.org/0009-0002-9238-4752
Komljenovic, Andrea
Lam, Hon Shing https://orcid.org/0009-0009-4386-1461
Vogel, Andrea https://orcid.org/0000-0002-2613-140X
Bausbacher, Tobias https://orcid.org/0000-0003-4384-5612
Riedl, Christian J.
Sango, Roko https://orcid.org/0009-0001-4314-3517
Matejovicova, Lenka
Dobrijevic, Anja
Oberbichler, Laura https://orcid.org/0009-0002-9925-6710
Hofmann, Melanie https://orcid.org/0000-0002-0835-4183
Kieler, Markus https://orcid.org/0000-0002-4082-5731
Quemada Garrido, Lucia
Perko Budja, Lara Veronika
Brunner, Julia Stefanie https://orcid.org/0000-0002-3195-147X
Cairns, James Lucas https://orcid.org/0000-0003-4986-1015
Cheng, Paul
Kitt, Kerstin
Isaguirre, Christine
Köcher, Thomas
Klavins, Kristaps
Rattei, Thomas
Hametner, Simon
Blüml, Stephan https://orcid.org/0000-0002-2758-4400
Hopf, Carsten https://orcid.org/0000-0003-0802-6451
Sheldon, Ryan D. https://orcid.org/0000-0002-1573-9719
Sharif, Omar https://orcid.org/0000-0001-7899-2343
Schabbauer, Gernot https://orcid.org/0000-0002-7490-8009
Funding for this research was provided by:
Austrian Science Fund (31568)
Austrian Science Fund (SFB-F83)
Austrian Science Fund (30026)
Christian Doppler Forschungsgesellschaft (CDL Inspired)
Christian Doppler Forschungsgesellschaft (CDL Arginine Metabolism)
Österreichischen Akademie der Wissenschaften
Deutsche Forschungsgemeinschaft (SFB 1389 (Project number 404521405))
Bundesministerium für Bildung und Forschung
Article History
Received: 6 June 2024
Accepted: 13 April 2026
First Online: 18 May 2026
Competing interests
: P.C. is the founder of Bio Cancer Treatment International. P.C. and G.S. are listed as inventors on a patent (US9789169B2) covering recARG1. K. Kitt is an employee of Boehringer Ingelheim Pharma. All other authors have no competing interests.